Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)

Market Cap	90.96B +18.1%
Revenue (ttm)	13.66B +47.5%
Net Income	1.80B +26.9%
EPS	18.73 +20.3%
Shares Out	96.35M
PE Ratio	50.40
Forward PE	40.82
Dividend	1.00 (0.11%)
Ex-Dividend Date	Aug 14, 2026

Volume	247,574
Open	947.80
Previous Close	953.70
Day's Range	935.00 - 963.70
52-Week Range	538.25 - 1,184.00
Beta	1.00
Analysts	Strong Buy
Price Target	1,163.75 (+23.28%)
Earnings Date	Nov 3, 2026

About NSE:YATHARTH

Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surger...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2008
• Employees: 7,440
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: YATHARTH

Financial Performance

In fiscal year 2026, NSE:YATHARTH's revenue was 12.07 billion, an increase of 36.31% compared to the previous year's 8.86 billion. Earnings were 1.75 billion, an increase of 34.34%.

Analyst Summary

According to 4 analysts, the average rating for YATHARTH stock is "Strong Buy." The 12-month stock price target is ₹1,164, which is an increase of 23.28% from the latest price.

Price Target

₹1,164

(23.28% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 28, 2026

Data Sources Report a data error